Evidence map›Paper›PMID 32964394›Full record

ArticleMolecular and cellular biochemistry2021

The anticarcinogen activity of β-arbutin on MCF-7 cells: Stimulation of apoptosis through estrogen receptor-α signal pathway, inflammation and genotoxicity.

Ömer Hazman, Ayşenur Sarıova, Mehmet Fatih Bozkurt, İbrahim Hakkı Ciğerci

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. 3,3'-Di-O-methylellagic Acid Isolated fromPharmaceuticals (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Recent Progress on Feasible Strategies for Arbutin Production.Frontiers in bioengineering and biotechnology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ömer HazmanDepartment of Chemistry, Faculty of Science and Arts, Afyon Kocatepe University, Afyonkarahisar, Turkey. omerhazman@hotmail.com.ORCID http://orcid.org/0000-0002-2702-6847
Ayşenur SarıovaDepartment of Chemistry, Faculty of Science and Arts, Afyon Kocatepe University, Afyonkarahisar, Turkey.ORCID http://orcid.org/0000-0003-2792-699X
Mehmet Fatih BozkurtDepartment of Patology, Faculty of Veterinary Medicine, Afyon Kocatepe University, Afyonkarahisar, Turkey.ORCID http://orcid.org/0000-0002-1669-0988
İbrahim Hakkı CiğerciDepartment of Molecular Biology and Genetics, Faculty of Science and Arts, Afyon Kocatepe University, Afyonkarahisar, Turkey.ORCID http://orcid.org/0000-0002-3626-7730
Afyon Kocatepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arbutin is one of the active ingredients employed in cosmetics as a skin whitening agent. In the present study, the possible effects of arbutin on breast cancer were determined with human breast adenocarcinoma (MCF-7) cells. α and β-arbutin cytotoxicity levels in MCF-7 cells were determined with the MTT method. At low (1-10 mM) doses, α-arbutin appears to be more toxic than β-arbutin. At higher (5-200 mM) and LD

Indexed as

Anticarcinogenic AgentsApoptosisArbutinBreast NeoplasmsCell Line, TumorCell ProliferationCell SurvivalComet AssayDNA DamageEndoplasmic Reticulum StressEstrogen Receptor alphaFemaleHumansInflammationMCF-7 CellsMicronucleus TestsAnticarcinogenic AgentsArbutinESR1 protein, humanEstrogen Receptor alphaMutagensArbutinCancerInflammationMCF-7 cellsOxidative stress

Identifiers

PMID32964394
OpenAlexW3088221270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.